Evidence map›Paper›PMID 26785754›Full record

ArticleScientific reports2016

Heterologously-expressed and Liposome-reconstituted Human Transient Receptor Potential Melastatin 4 Channel (TRPM4) is a Functional Tetramer.

Maryrose Constantine, Chu Kong Liew, Victor Lo, Alex Macmillan, Charles G Cranfield, Margaret Sunde, Renee Whan, Robert M Graham, Boris Martinac

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  2. Article
  3. Review
  4. Article
  5. The CaeLife · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Maryrose ConstantineVictor Chang Cardiac Research Institute, Lowy Packer Building, NSW 2010.
Chu Kong LiewVictor Chang Cardiac Research Institute, Lowy Packer Building, NSW 2010.
Victor LoSchool of Medical Sciences, The Bosch Institute, The University of Sydney, NSW 2006.
Alex MacmillanBiomedical Imaging Facility, Lowy Cancer Research Centre, The University of New South Wales, Kensington, NSW 2052, Australia.
Charles G CranfieldSchool of Life Sciences, University of Technology Sydney.
Margaret SundeSchool of Medical Sciences, The Bosch Institute, The University of Sydney, NSW 2006.
Renee WhanBiomedical Imaging Facility, Lowy Cancer Research Centre, The University of New South Wales, Kensington, NSW 2052, Australia.
Robert M GrahamVictor Chang Cardiac Research Institute, Lowy Packer Building, NSW 2010.
Boris MartinacVictor Chang Cardiac Research Institute, Lowy Packer Building, NSW 2010.
UNSW Sydney · AURobert Bosch (Australia) · AUSt Vincent's Clinic · AUUniversity of Sydney · AUUniversity of Technology Sydney · AUVictor Chang Cardiac Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutation, irregular expression and sustained activation of the Transient Receptor Potential Channel, type Melastatin 4 (TRPM4), have been linked to various cardiovascular diseases. However, much remains unknown about the structure of this important ion channel. Here, we have purified a heterologously expressed TRPM4-eGFP fusion protein and investigated the oligomeric state of TRPM4-eGFP in detergent micelles using crosslinking, native gel electrophoresis, multi-angle laser light scattering and electron microscopy. Our data indicate that TRPM4 is tetrameric, like other TRP channels studied to date. Furthermore, the functionality of liposome reconstituted TRPM4-eGFP was examined using electrophysiology. Single-channel recordings from TRPM4-eGFP proteoliposomes showed inhibition of the channel using Flufenamic acid, a well-established inhibitor of TRPM4, suggesting that the channels are functional upon reconstitution. Our characterisation of the oligomeric structure of TRPM4 and the ability to reconstitute functional channels in liposomes should facilitate future studies into the structure, function and pharmacology of this therapeutically relevant channel.

Indexed as

Gene ExpressionProtein MultimerizationGreen Fluorescent ProteinsHumansLiposomesMolecular ImagingProtein TransportProteolysisRecombinant Fusion ProteinsTRPM Cation Channelsenhanced green fluorescent proteinGreen Fluorescent ProteinsLiposomesRecombinant Fusion ProteinsTRPM4 protein, humanTRPM Cation Channels

Identifiers

PMID26785754
PMCPMC4726259
OpenAlexW2283629047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.